Skip to main content

Table 3 Diabetes complications

From: Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes

 

T2DM without LGE

T2DM with ischemic LGEa

T2DM with non-ischemic LGE

P-valueb

P-valuec

Albuminuria (%)

72 (35)

17 (55)

8 (32)

0.09

Retinopathy (%)

51 (25)

8 (28)

12 (48)

0.054

0.009

Autonomic neuropathy (%)

62 (30.5)

14 (47)

13 (52)

0.03

0.005

Peripheral neuropathy (%)

78 (40)

15 (52)

12 (50)

0.34

Beat-to-beat variation (bpm)

11.1 IQR6.8–17.8

7.3 IQR3.4–11.9

6.5 IQR3.9–11.0

0.0003

0.0029

Beat-to-beat ≤ 6 (%)

55 (27)

14 (44)

12 (50)

0.01

0.02

Orthostatic blood pressure fall (mmHg)

12.0 IQR5–18

11.5 IQR4–19.5

13.0 IQR5–21

0.34

Orthostatic blood pressure fall ≥ 25 (%)

27 (13)

6 (19)

3 (12)

0.66

  1. Data presented as median and interquartile range (IQR) or as nominal values with percentages in parentheses
  2. aIncluding three patients with both ischemic and non-ischemic lesions
  3. bComparison between all three groups as appropriate
  4. cComparison between T2DM patients with non-ischemic LGE vs. T2DM patients without LGE